Ftse Mib
33.494,83
0,60%
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.717,97
-0,32%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vincerx Inc (VINC) Vincerx Inc (VINC) Notizie

Vincerx Inc

VINC
0,2531
-0,0029 (-1,13%)
23 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/11/202415:04EDGAR2Form 8-K - Current report
12/11/202415:00GLOBEVincerx Pharma Reports Third Quarter 2024 Financial Results
05/11/202415:15EDGAR2Form PRE 14A - Other preliminary proxy statements
07/10/202422:05GLOBEVincerx Reports Positive Initial Clinical Data from Ongoing..
30/9/202412:57EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
10/9/202422:02EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
19/8/202422:01EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
16/8/202422:01EDGAR2Form 8-K - Current report
15/8/202402:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202402:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202422:06EDGAR2Form SC TO-I - Tender offer statement by Issuer
08/8/202422:39EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:37EDGAR2Form 8-K - Current report
08/8/202422:30GLOBEVincerx Pharma Reports Second Quarter 2024 Financial Results
02/8/202422:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/7/202422:45EDGAR2Form DEF 14A - Other definitive proxy statements
30/5/202403:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202403:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:06EDGAR2Form 8-K - Current report
14/5/202422:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:21EDGAR2Form 8-K - Current report
14/5/202422:15GLOBEVincerx Pharma Reports First Quarter 2024 Financial Results..
26/4/202406:27GLOBEVincerx Pharma Announces Pricing of Underwritten Public..
25/4/202422:01GLOBEVincerx Pharma Announces Proposed Underwritten Public..
08/4/202422:30GLOBEVincerx Pharma Presents Positive Preliminary Phase 1 Data..
01/4/202414:00GLOBEVincerx to Host Virtual Investor Event Reviewing Preliminary..
29/3/202420:20GLOBEVincerx Pharma Reports Fourth Quarter and Full Year 2023..
09/3/202402:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/3/202402:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:31GLOBEVincerx to Present Three Posters at the American Association..
16/1/202412:05EDGAR2Form 8-K - Current report
Apertura: 0,251736 Min: 0,2435 Max: 0,2684
Chiusura: 0,256

La tua Cronologia

NASDAQ
VINC
Vincerx
NASDAQ
DTPI
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network